Related Experiment Video
Updated: Jan 15, 2026

Detection of Mitochondria Membrane Potential to Study CLIC4 Knockdown-induced HN4 Cell Apoptosis In Vitro
Published on: July 17, 2018
SLIT2 modulates NMIIA to regulate mitophagy and suppress hepatocellular carcinoma progression
Yong Qin1, Junbin Zhou1, Shimiao Li1
1Department of Hepatobiliary Pancreatic Surgery, Lishui Hospital of Wenzhou Medical University, The First Affiliated Hospital of Lishui University. Lishui People's Hospital, East of the intersection of National Highway 330 and Liyang Street, Liandu district, Lishui, Zhejiang, 323000, China.
Abstract:
Hepatocellular carcinoma (HCC) is characterized by aggressive progression and metastasis, driven by complex molecular interactions. This study elucidates the functional roles of slit guidance ligand 2 (SLIT2) and non-muscle myosin IIA (NMIIA) in HCC and explores their mechanistic interplay. Immunofluorescence and quantitative PCR (Q-PCR) analyses demonstrated significant downregulation of SLIT2 and upregulation of NMIIA in HCC tissues, with SLIT2 expression inversely correlating with tumor stage and metastatic propensity, as validated by The Cancer Genome Atlas (TCGA) dataset. Functional assays revealed that SLIT2 overexpression attenuated HCC cell proliferation, migration, and invasion, whereas NMIIA overexpression markedly enhanced these oncogenic properties. Mechanistically, NMIIA facilitated epithelial-mesenchymal transition (EMT) and mitophagy, potentiating tumor progression. Conversely, SLIT2 overexpression inhibited myosin regulatory light chain (MRLC) phosphorylation, thereby suppressing NMIIA activity, EMT, and mitophagy. SLIT2 also diminished cell adhesion, while NMIIA enhanced adhesion and colony-forming capacity. In vivo xenograft studies corroborated that SLIT2 depletion accelerated tumor growth. These findings establish the SLIT2/NMIIA axis as a critical modulator of HCC progression and a promising therapeutic target.
Insights
Slit guidance ligand 2 (SLIT2) and non-muscle myosin IIA (NMIIA) play key roles in hepatocellular carcinoma (HCC) progression. Targeting the SLIT2/NMIIA axis offers a promising therapeutic strategy for HCC treatment.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Hepatocellular carcinoma (HCC) exhibits aggressive progression and metastasis.
- Complex molecular interactions drive HCC development and spread.
Purpose of the Study:
- To elucidate the roles of slit guidance ligand 2 (SLIT2) and non-muscle myosin IIA (NMIIA) in HCC.
- To explore the mechanistic interplay between SLIT2 and NMIIA in HCC progression.
Main Methods:
- Immunofluorescence and quantitative PCR (Q-PCR) for gene expression analysis.
- Functional assays to assess cell proliferation, migration, and invasion.
- In vivo xenograft studies in mice.
- Analysis of The Cancer Genome Atlas (TCGA) dataset.
Main Results:
- SLIT2 was significantly downregulated, while NMIIA was upregulated in HCC tissues.
- SLIT2 expression inversely correlated with tumor stage and metastasis.
- SLIT2 overexpression inhibited HCC cell growth and metastasis.
- NMIIA overexpression enhanced HCC cell proliferation, migration, invasion, epithelial-mesenchymal transition (EMT), and mitophagy.
- SLIT2 suppressed NMIIA activity by inhibiting MRLC phosphorylation.
- NMIIA enhanced cell adhesion and colony formation.
Conclusions:
- The SLIT2/NMIIA axis is a critical regulator of HCC progression.
- SLIT2 acts as a tumor suppressor, while NMIIA promotes oncogenesis in HCC.
- Targeting the SLIT2/NMIIA pathway presents a potential therapeutic strategy for HCC.
More Related Videos
09:32Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity
Published on: October 17, 2025
07:40Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
Related Concept Videos
MicroRNAs
MicroRNAs
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...